Long‐term outcome prediction for chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23900
Abstract: The definitive treatment for chronic thromboembolic pulmonary hypertension (CTEPH) is pulmonary endarterectomy (PEA), which has good long‐term outcomes. However, after surgery, a quarter of the patients still have residual pulmonary hypertension (RPH). In pulmonary hemodynamics,… read more here.
Keywords: long term; pulmonary hypertension; thromboembolic pulmonary; chronic thromboembolic ... See more keywords
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14033
Abstract: Repeated risk assessments and treatment patterns over long time are sparsely studied in chronic thromboembolic pulmonary hypertension (CTEPH); thus, we aimed to investigate changes in risk status and treatment patterns in incident patients with CTEPH… read more here.
Keywords: pulmonary hypertension; thromboembolic pulmonary; risk; treatment patterns ... See more keywords
Evaluation of the effect of nitric oxide inhalation in the patients with chronic thromboembolic pulmonary hypertension or pulmonary disease during balloon pulmonary angioplasty
Sign Up to like & getrecommendations! Published in 2022 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12032
Abstract: Abstract Balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary disease (CTEPD) is performed worldwide. High mean pulmonary arterial pressure (mPAP) during BPA is associated with aggravation of procedure‐related complications. Inhaled nitric… read more here.
Keywords: procedure; thromboembolic pulmonary; pulmonary angioplasty; balloon pulmonary ... See more keywords
Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy
Sign Up to like & getrecommendations! Published in 2022 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12110
Abstract: Abstract Patients with chronic thromboembolic pulmonary hypertension (CTEPH) require lifelong anticoagulant therapy. The safety and efficacy of direct oral anticoagulant (DOAC) in the chronic and transitional management of CTEPH has not been investigated. We performed… read more here.
Keywords: pulmonary hypertension; patients chronic; recent thrombus; thromboembolic pulmonary ... See more keywords
Analysis of family histories suggests shared genetic risk for chronic thromboembolic pulmonary hypertension and venous thromboembolism
Sign Up to like & getrecommendations! Published in 2022 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12170
Abstract: Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) and acute pulmonary embolism (PE) are related phenotypes, however, previous reports have suggested that genetic risk factors for CTEPH and PE differ. Here we report that a family history… read more here.
Keywords: pulmonary hypertension; shared genetic; thromboembolic pulmonary; risk ... See more keywords
Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study
Sign Up to like & getrecommendations! Published in 2022 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12181
Abstract: Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) is believed to involve both vascular obstruction and vasoconstriction; hence, pulmonary vasodilators such as riociguat may be beneficial. Acute vasoreactivity testing (AVT) is seldom performed routinely in CTEPH patients,… read more here.
Keywords: pulmonary hypertension; thromboembolic pulmonary; vasoreactivity testing; pulmonary vascular ... See more keywords
Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Comparison of changes in hemodynamics and functional capacity
Sign Up to like & getrecommendations! Published in 2023 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12199
Abstract: Abstract The treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH) is pulmonary endarterectomy (PEA). Balloon pulmonary angioplasty (BPA) is an emerging option for inoperable patients. Comparisons of the hemodynamic and functional outcome between these… read more here.
Keywords: pulmonary hypertension; capacity; thromboembolic pulmonary; bpa ... See more keywords
Automated quantification of the pulmonary vasculature in pulmonary embolism and chronic thromboembolic pulmonary hypertension
Sign Up to like & getrecommendations! Published in 2023 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12223
Abstract: Abstract The shape and distribution of vascular lesions in pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH) are different. We investigated whether automated quantification of pulmonary vascular morphology and densitometry in arteries and veins… read more here.
Keywords: pulmonary hypertension; automated quantification; embolism chronic; pulmonary embolism ... See more keywords
Evolution of patients with chronic thromboembolic pulmonary hypertension treated by balloon pulmonary angioplasty, according to their anticoagulant regimens
Sign Up to like & getrecommendations! Published in 2021 at "Heart and Vessels"
DOI: 10.1007/s00380-021-01799-x
Abstract: Patients with chronic thromboembolic pulmonary hypertension (CTEPH) need anticoagulant therapy for life. Conventionally, vitamin K antagonists (VKAs) have been used and data about direct oral anticoagulants (DOACs) in CTEPH patients are lacking. Recently, balloon pulmonary… read more here.
Keywords: chronic thromboembolic; pulmonary hypertension; bpa; patients chronic ... See more keywords
Chronic Thromboembolic Pulmonary Hypertension: the Bedside
Sign Up to like & getrecommendations! Published in 2021 at "Current Cardiology Reports"
DOI: 10.1007/s11886-021-01573-5
Abstract: Chronic thromboembolic pulmonary hypertension (CTEPH), included in group 4 PH, is an uncommon complication of acute pulmonary embolism (PE), in which emboli in the pulmonary vasculature do not resolve but rather form into an organized… read more here.
Keywords: chronic thromboembolic; pulmonary hypertension; hypertension bedside; cteph ... See more keywords
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Sign Up to like & getrecommendations! Published in 2019 at "Cardiovascular Intervention and Therapeutics"
DOI: 10.1007/s12928-019-00637-2
Abstract: Chronic thromboembolic pulmonary hypertension (CTEPH) is classified as Group-4 pulmonary hypertension caused by organized thrombi in pulmonary arteries. Pulmonary endarterectomy (PEA) has been shown to improve the symptoms and prognoses of patients with proximal CTEPH.… read more here.
Keywords: chronic thromboembolic; pulmonary hypertension; pulmonary angioplasty; thromboembolic pulmonary ... See more keywords